The Chinese Defense Ministry said in a statement on Tuesday that it had "successfully" developed a vaccine against the new SARS-CoV-2 coronavirus, which causes COVID-19 pneumonia, and has authorized human tests, although the text he did not specify when such trials would begin.

According to the note, the Chinese Ministry of Defense has approved human clinical trials of a coronavirus vaccine. Behind this finding is the research team led by epidemiologist Chen Wei of the Military Academy of Medical Research, reporting to the Military Academy of Sciences.

It should be noted that several Chinese institutions announced that they will launch clinical trials in April to verify the efficacy of various vaccines that the country is developing against the virus.

Accordin to the Chinese Ministry of Education, there is on the table a vaccine based on viral influenza vectors that is currently undergoing experimentation with animals that will begin its clinical trials in April with the participation of the universities of Beijing, Tsinghua and Xiamen, as well as other research institutions, according to the state news agency Xinhua.

Three new products used in diagnostic tests to detect the coronavirus have been clinically approved and applied in Shanghai.

Furthermore, the deputy director of the Shanghai Municipal Health Commission said that Chinese scientists have developed a vaccine on the mRNA platform that will enter clinical trials also in April.

He also pointed out that it has been developed based on viral proteins derived from the structural proteins of a virus.

Meanwhile, three new products used in diagnostic tests to detect coronavirus have been clinically approved and applied in Shanghai, said Zhang Quan, director of the city's science and technology commission, today.

While we wait for new news in this regard, we appeal to everyone to comply with the preventive measures recommended by specialists to prevent the spread of the infection.